New supplement MB-1 aims to shed pounds in overweight adults

NCT ID NCT07363148

Not yet recruiting Disease control Sponsor: Arrae Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests whether a dietary supplement called MB-1 can help overweight and obese adults lose weight and improve metabolic health. One hundred participants will take either MB-1 or a placebo daily for 84 days. Researchers will measure changes in body weight, BMI, and other health markers to see if MB-1 is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MB-1 (dietary supplement)
What this could lead to: If it works, this could offer a new dietary supplement to help with weight loss and improve metabolic health in overweight adults.
What could go wrong: This is an early-stage trial with only 100 participants, so results may not apply to everyone. The supplement may not cause significant weight loss compared to placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BMI are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BMI BODY WEIGHT CONTROL OBESE OBESE ADULTS OVERWEIGHT ADULTS

Contacts and locations

Locations

KGK Science Inc.

London, Ontario, N6B3L1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.